Leaders from Pfizer, Sanofi, Eli Lilly and Applied Informatics to Speak on Artificial Intelligence at Pharma Innovation Conference
Dr. Chintan Patel to discuss the implementation of AI & machine learning in clinical development.
New York, NY, July 19, 2018 --(PR.com)-- Leading computer scientist and informatician, Dr. Chintan Patel (CTO of Applied Informatics) will be presenting the life science industry’s first end-to-end machine learning platform to accelerate drug development. Dr Patel will speak at the 1st AI Pharma Innovation: Clinical Development Summit on July 25th 2018. He will be joined by high-profile industry experts at the forefront of digital transformation in life sciences, to discuss how AI and machine learning could revolutionize traditional drug development practices by enabling first mover organizations to leverage the untapped potential of clinical trials data.
As the race heats up for better life-saving therapies, AI and machine learning holds remarkable promise for quicker, cheaper and more-effective drug development. According to Dr. Patel, “AI and Machine Learning have revolutionized industries such as automobiles, logistics and finance, and we are beginning to see similar disruption happening in pockets across the pharma industry. Several current inefficient processes will be replaced with data-driven, self-optimizing AI processes.” With over 15 years of experience building solutions for the life sciences industry, and his expertise in semantic technologies, biomedical ontologies, machine learning and natural language processing, Dr. Patel’s talk will draw upon a wealth of knowledge to round out the panel of industry experts.
The conference will include feature speakers from innovative life science companies including Pfizer, GSK, Merck, Berg, Medidata, InSilico Medicine, Eli Lilly, Sanofi, Lantern Pharma, Bill & Melinda Gates Medical Research Institute, Abbvie & Takeda.